MedifastMED -2.45%69 FCF Yield % is -1.28 as of Jun. 25, 2026. GuruFocus rates MED with a GF Score™ of 69/100 and a GF Value™ of $8.75 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 99 Personal Services companies, Medifast ranks worse than 63.64% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Medifast FCF Yield % Related Terms
Medifast FCF Yield % Historical Data
* Premium members only.
The historical data trend for Medifast's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Personal Services subindustry, Medifast's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medifast FCF Yield % vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Medifast's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Medifast's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medifast (MED) has a FCF Yield % of -1.28 as of Jun. 25, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medifast and its competitors. According to the industry distribution chart, Medifast ranks #63 out of 99 companies in the Personal Services industry, placing it in the top 63.6%.
Is Medifast's FCF Yield % too high?
Medifast's current FCF Yield % is -1.28. Based on the distribution chart, Medifast ranks #63 out of 99 companies in the Personal Services industry, which is below the industry midpoint. Overall, Medifast has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's FCF Yield % compare to RGS and VGES?
According to the Personal Services industry distribution chart, Medifast ranks #63 out of 99 companies for FCF Yield %. This places Medifast in the lower half of its industry. The industry median FCF Yield % is 3.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Personal Services company?
The median FCF Yield % among Personal Services companies is 3.28, based on 99 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medifast and its competitors. For the Personal Services industry, the median FCF Yield % is 3.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medifast's current FCF Yield % is -1.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (MED) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.75, compared to a current price of $10.36 — trading 18.4% above its estimated fair value. The current FCF Yield % is -1.28. Medifast's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Medifast (MED), the current FCF Yield % is -1.28 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medifast (MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medifast stock appears to be overvalued.
The current stock price of $10.36 is trading 18.4% above its estimated GF Value™ of $8.75.
GuruFocus considers Medifast to be Modestly Overvalued.
Key valuation signals for MED:
FCF Yield %: -1.28
GF Value™: $8.75 vs. price of $10.36 (18.4% above fair value)
No single metric tells the full story. See the MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
69GF Score
Get the complete analysis for MED
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MED has been successfully added to your 
